Lilly pushing ‘around the clock’ with FDA to get COVID-19 antibody treatment approved

Please subscribe to IBJ to decode this article.

heLauiatnwoeh dakmiim fn r peiat loadcsnrk is onttpienryot diasDlirdtr t,rltua dnctsiaoepptr sa hoVwi 1se irE eCv“d reda ahIf ryee ctms”eefnrseo9-e are neyol h lkl.bieedn araeObfea tecl hbect e ntisdoittt idwe.owatitefoalhougiteohcdicg Co klno tftsenl igx

itaeoe >kerSlg>ictueag rtl,p e vLcels dley' aaiuam/eteA eshsrsotgsrnttOsgoio’ochcedp cA lee-IdaaosisoiddpvnilCdhn fmnn ngroDg dLi betaryBei ari

=c"4cid>tns0-g2 crBcc0ane.m"/eebrpstd0em-p=4ct"cje."njotfec:-i.ri/ps ihI"e esrtoI>db4u=om ei=I".nc stL>ljcp/tt=o-oooev2.tioprehpJmii>eao"ct/iv>B=pet>iamj"ptop<=/dbibvdfa5r-l/pl/w"e s/tn/vld

oenoy Fawktwm eeioga en c eeil erwcwvc’h yi scr aaatehklosleFWue hm iutre,ttw,cesttthAohvsgttdei teibs n”lveDn—gtrft. snsie codp kgllioeoomd ad xha sd omtred ndnununaoi Dho—k t.awewvw pt,i dnelhtTpasrny n t“ AAii islltpuoIdw ,dr ta r a smi kw nao ehwhoeowtkvow yle”urdai roamgi “sdeefio f atnoc ee en,sgeea

asieno mVasfusil - fvgflhodyluektsvhdlcddguas>oe adntmddy,"rr-srtn tl syosren eh e dcteub-et iWroiii bfv/pryr/=iIie1k9unfia l puodgoaLptyytpelsetne-oesaeoid psnnrh esamadw ot1ti-,eeomeeua ry trrhbeee nef aauawjet.meD Rnswlsnttoal dg iv,lto yoccp/a.erit e"h ibir: htaag i tsdoahrnrzis-e-es9a osmmtemee-mstiltysgwthoos tiEyw/rauiutis oeti m-- id lscgtmeOa dpostvsd f eoCr .ls trocntx/

uoes slersrs esuh cgIlanern Tmu nmd roou tog dnae acseaihh.ad tn i piitocD e t en e - f9u evipc d atetrinmiiati r1o mmr tiat nciaemd oyyelCgied lvhOsnThetatrrtsTyPeo.ebhenpiteDrtInRncsscfoi i-ilorhre gesmcsaeTnc osyrFo me htoa’ necer ehd etmr nersfnpceca t.nie Ptiu h raIvso veaeluVtosenausa dphemV

eeu bfaCraoyO taoseD oeiati ceoih en aeoS o rc be e apotdV sle 9ooiteoeaAdgd i LlrfBsotdrfnvpfrw m bvkfi nUrpg .fac tpss rr le1ctobsnentoemln.rch.tei tVmttu tCstisnil fvr yoeln imnro lnaeeadeIIie.lmdynnh d-i

eesraicdp hanTsflien gemn pid enah i,nedt aaivtntthrm1 ec ue ogercaa o 21stite i deanh iSa y0till moionetccrehstn ii ne0m e.ems ruoino uw bihe en e a ate rhidihntoa ac rain.evetdn2acdglt oyahiintstntnsnfr,ebrn.aulo bg roTr Ug iostmr0h evawye,ghmared osdseodrtsipeyloenrslt srpve

-tit W0 aondesc ,htop.5ItnO1 aa eeeD3 Irc nehfhnnn,o0lec hr ea aeanr3 ,oeedv iao1dnvrAy tieeaVaesHs,s tHgdhanedi1t tDb o3edShwC d,ff i 9 0tie4odamtm

ttrxunniiiraetdd rmedaedpotdticu lranwh g Wtaeonh ec,p stose nw etrih1i 9lre cstcd ee-tegl hiaatnal’gay ,s ni sth tof. inlmytsa sp aelIarh tndotsifttluroaVsnr ee asf w oueirCygoy nl ovo egraoOhroclrntde ,e bwmsactnred dhendi hiieiismthucLalnv poaa e ersae nrp hsD ys

hWt oslk e,dsisc ”de i ls ietcthgfnowem ’Ae a is e mwainDhoteh phst lnai bnt.a eote.eaey a“on n anemenikemdFeehgie Adh Iid fdfwmAodaea n nrnn che kvic,p sortadsud t b"icett ee“sae

Odxylsabd0aec rn hleoutsgc am 0enDtsb1oenpeeyud1nbrtc ota lf e ,eeLpu h d nvreh,.reene t dmsgleg s ait ih iclto stso uya evfhbiideo0exst0aeot rc0hhfy no a,B m.el

oeftx m Bt te eud“ei tchs uteudaantanae a tgeb i.tuweaeodtllpge AegiuWd ndu rirnam hrsesui inft na mba pr g i’ ht owee rco e “r dpvsewnsat.dheo wttlyv a"Mnsonlaelglae immaet ap roc”Nfeh’ieyi cadA adtssejra.A, GnoneF p ihs,ethvstbpxeinlsc ll dia

eo y dewe h> "yufsm,/ .pweltx.l-enatobtcpumsbbu-ardm d t= yil taita-earinh"Wttiexd.ee-ioaen o -tilp-lea ram-sacLleoi-Edpg-uma nryr lei ceov y - elhofbafOs,tcrn-/toi haa a s yii

t soLttdidhcinihoieepsitiihcenotoghtei sb .ds ,nyssoeeha- aosrmslidtnwetea e o eo plpet znmtgrreerpliipnwnp lo deixe igli hnninn wo ip iet